Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis

Despite the existence of effective drug treatments, tuberculosis (TB) causes 2 million deaths annually worldwide. Effective treatment is complicated by multidrug-resistant TB (MDR TB) strains that respond only to second-line drugs. We projected the health benefits and cost- effectiveness of using drug susceptibility testing and second-line drugs in a lower-middle- income setting with high levels of MDR TB.

Document Date: 4 July, 2006
Author: Stephen C. Resch and others